Both in Biotechnology
Entera Bio vs Editas Medicine
Over the past year ENTX returned +14.3% and EDIT returned −3.6%; their daily moves had a correlation of 0.18.
ENTX +14.3% EDIT −3.6%Growth of $1, one year, split-adjusted
| Metric | ENTX | EDIT |
|---|---|---|
| Price | $3.12 | $2.93 |
| Market cap | $542.6M | $450.0M |
| Today | +0.65% | −0.68% |
| 1 month | +7.2% | +14.0% |
| 6 months | +162.2% | −2.3% |
| Year to date | +60.8% | +42.9% |
| 1 year | +23.8% | −7.6% |
| Revenue growth (YoY) | — | +232.3% |
| Gross margin | — | 100.0% |
| Net margin | — | −153.3% |
| P/E (TTM) | — | — |
| Price / sales | — | 9.6× |
| Net cash | $11.0M | $155.9M |
| Dividend yield | — | — |
| Volatility (60d) | 61.7% | 79.9% |
| Short % of float | 3.5% | 25.7% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).